FdaApplication
ANDA 216159
Identifiers
- fda_app_no: ANDA216159
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2023-04-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MIDAZOLAM IN 0.9% SODIUM CHLORIDE | MIDAZOLAM | 100MG/100ML (1MG/ML) | SOLUTION;INTRAVENOUS |
| MIDAZOLAM IN 0.9% SODIUM CHLORIDE | MIDAZOLAM | 50MG/50ML (1MG/ML) | SOLUTION;INTRAVENOUS |
2 products